Topic Archives: antibiotics

FOR EXPONENTIAL TECH, regarding a small biotech: ”In July 2018, this biotech announced positive results for its Phase 1 clinical trials. And get this. This drug has been used for many years in Japan with few adverse side effects. Because of this, the FDA granted the drug a qualified infectious disease product designation. In other […]

The headline that snagged my attention was this:  ‘Thirty-five Thousand Americans Die of Antibiotic-Resistant Infections Each Year” This was based on the Centers for Disease Control’s Antibiotic Resistance Threats in the United States, 2019, which led off with the statement that more than 2.8 million antibiotic-resistant infections occur in the US every year, and more […]

Comments

  • Avatar

    From Bill Bonner's letter Why China Is Buying Gold Miners… And Why You Should Too Editor's Note: On Thursday, g...

  • Avatar

    Re 1-1-8 pitch wherein Dave Forest makes ref to "RF" (Robert Friedland), <$2.00 stock, etc. A year or so past I reca...

  • Avatar

    Re 1-1-8 pitch wherein Dave Forest gives ref to "RF" (Robert Friedland), <2.00/sh, large shareholder, etc. Is he ref...

  • Avatar

    Did you to listen to the latest report from Dave Forest (Casey Research) on 11/7/2018? He mentioned 2 stocks to buy befo...

  • Avatar

    Platinum metals group comples and South African commentary courtesy Dave Forest. Very notable price action across the...

  • Avatar

    South African mining information from Pierce Points, Dave Forest. South Africa's Chamber of Mines made a surprise mov...

  • Avatar

    DRC news courtesy Dave Forest (dforest@piercepoints.com) As I've been discussing for several months, governments in m...

  • Avatar

    Dave Forest recommended Abertis Infraestructures (Otc::a try) and said he would consider adding to his portfolio but was...

  • We use cookies on this site to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies.

    More Info